Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With Acute and Advanced Heart Failure With Renal Insufficiency
Clinical trial NCT06205758 · UNKNOWN
Trial details
- NCT number
- NCT06205758
- Sponsor
- Yi Han
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-16
- Primary completion
- 2025-06-01
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.